keyword
MENU ▼
Read by QxMD icon Read
search

Integrative oncology

keyword
https://www.readbyqxmd.com/read/28078132/impressive-response-to-dual-braf-and-mek-inhibition-in-patients-with-braf-mutant-intrahepatic-cholangiocarcinoma-2-case-reports-and-a-brief-review
#1
Viraj Lavingia, Marwan Fakih
Intrahepatic cholangiocarcinoma (ICC) typically presents at an advanced stage and is associated with a poor oncological outcome. The median survival for metastatic ICC is less than 1 year with standard chemotherapy. ICC is associated with distinct oncogenic drivers including IDH (isocitrate dehydrogenase), HER-2 (human epidermal growth factor 2), and BRAF (v-Raf murine sarcoma viral oncogene homolog B), which may benefit from matching targeted therapies. Hereby we report 2 cases of BRAF V600E refractory ICC treated with dual BRAF and MEK inhibitors (dabrafenib and trametinib) with excellent clinical and radiological response to therapy and with protracted duration of disease control...
December 2016: Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/28077836/-decision-making-experience-on-breast-reconstruction-for-women-with-breast-cancer
#2
Myungsun Yi, Woo Joung Joung, Eun Young Park, Eun Jin Kwon, Haejin Kim, Ji Young Seo
PURPOSE: The purpose of this study was to explore decision making experiences of Korean women with breast cancer who underwent breast reconstruction with/after a mastectomy. METHODS: Data were collected during 2015-2016 through individual in-depth interviews with 10 women who had both mastectomy and breast reconstruction, and analyzed using phenomenological method to identify essential themes on experiences of making a decision to have breast reconstruction. RESULTS: Five theme clusters emerged...
December 2016: Journal of Korean Academy of Nursing
https://www.readbyqxmd.com/read/28074412/a-scientific-rationale-to-improve-resistance-training-prescription-in-exercise-oncology
#3
Ciaran M Fairman, Michael C Zourdos, Eric R Helms, Brian C Focht
To date, the prevailing evidence in the field of exercise oncology supports the safety and efficacy of resistance training to attenuate many oncology treatment-related adverse effects, such as risk for cardiovascular disease, increased fatigue, and diminished physical functioning and quality of life. Moreover, findings in the extant literature supporting the benefits of exercise for survivors of and patients with cancer have resulted in the release of exercise guidelines from several international agencies...
January 10, 2017: Sports Medicine
https://www.readbyqxmd.com/read/28069908/clinical-and-prognostic-significance-of-anisocytosis-measured-as-a-red-cell-distribution-width-in-patients-with-colorectal-cancer
#4
Davor Kust, Marko Lucijanic, Kristina Urch, Ivan Samija, Ivana Celap, Ivan Kruljac, Marin Prpic, Ivica Lucijanic, Neven Matesa, Ante Bolanca
PURPOSE: colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, and detection of new prognostic markers is mandatory for patients to receive optimal oncological treatment. The aim of the study was to assess clinical and prognostic value of red cell distribution width (RDW) in patients with CRC. METHODS: RDW values in 90 patients with CRC undergoing surgery for primary disease were analyzed in pre- and postoperative setting, and correlated with clinical and hematological parameters...
January 9, 2017: QJM: Monthly Journal of the Association of Physicians
https://www.readbyqxmd.com/read/28069153/working-in-silos-head-neck-cancer-patients-during-and-after-treatment-with-or-without-early-palliative-care-referral
#5
Helena Ullgren, Lily Kirkpatrick, Sini Kilpeläinen, Lena Sharp
PURPOSE: The primary aim was to describe patients with Head and Neck (H&N) cancer referred to palliative care and how the care transition from acute oncological to palliative care impacted on both Health related quality of life (HRQoL) and information. The secondary aim was to explore H&N cancer patients' HRQoL and perceived information. METHODS: H&N cancer patients were identified via the Swedish Cancer Register. Data were collected using the following questionnaires; European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30, INFO25, and a study-specific questionnaire...
February 2017: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://www.readbyqxmd.com/read/28062331/perioperative-palliative-care-considerations-for-surgical-oncology-nurses
#6
REVIEW
Rebecca Sipples, Richard Taylor, Deborah Kirk Walker, Gulcan Bagcivan, J Nicholas Dionne-Odom, Marie Bakitas
OBJECTIVES: To explore the opportunities to incorporate palliative care into perioperative oncology patient management and education strategies for surgical oncology nurses. DATA SOURCES: Articles related to palliative care and surgical oncology to determine the degree of integration, gaps, and implications for practice. CONCLUSION: Although evidence supports positive patient outcomes when palliative care is integrated in the perioperative period, uptake of palliative care into surgical settings is slow...
January 4, 2017: Seminars in Oncology Nursing
https://www.readbyqxmd.com/read/28062330/minimally-invasive-cancer-surgery-indications-and-outcomes
#7
REVIEW
Virginia Sun, Yuman Fong
OBJECTIVES: To review the current evidence on the impact of minimally invasive, robotic-assisted cancer surgery (thoracic, gastrointestinal, gynecologic, genitourinary) on surgical outcomes and quality of life. DATA SOURCES: Journal articles, research reports, state of the science papers, and clinical guidelines. CONCLUSION: Minimally invasive cancer surgery is an important and integral component of the comprehensive care of cancer patients...
January 3, 2017: Seminars in Oncology Nursing
https://www.readbyqxmd.com/read/28057171/predicting-high-impact-pharmacological-targets-by-integrating-transcriptome-and-text-mining-features
#8
Anatoly Mayburd, Ancha Baranova
PURPOSE: Novel, "outside of the box" approaches are needed for evaluating candidate molecules, especially in oncology. Throughout the years of 2000-2010, the efficiency of drug development fell to barely acceptable levels, and in the second decade of this century, levels have improved only marginally. This dismal condition continues despite unprecedented progress in the development of a variety of high-throughput tools, computational methods, aggregated databases, drug repurposing programs and innovative chemistries...
October 2016: Journal of Pharmacy & Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences
https://www.readbyqxmd.com/read/28052061/integrated-genomic-characterization-of-oesophageal-carcinoma
#9
(no author information available yet)
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies and survival rates for these cancers remain dismal. Here we performed a comprehensive molecular analysis of 164 carcinomas of the oesophagus derived from Western and Eastern populations. Beyond known histopathological and epidemiologic distinctions, molecular features differentiated oesophageal squamous cell carcinomas from oesophageal adenocarcinomas. Oesophageal squamous cell carcinomas resembled squamous carcinomas of other organs more than they did oesophageal adenocarcinomas...
January 4, 2017: Nature
https://www.readbyqxmd.com/read/28050944/are-future-medical-oncologists-sufficiently-trained-to-communicate-about-palliative-care-the-medical-oncology-curriculum-in-flanders-belgium
#10
M Horlait, S Van Belle, M Leys
BACKGROUND: Palliative care is considered an integral part of oncology and communicating this with patients is an unavoidable task for oncologists. This contribution investigated to what extent communication skills for communicating palliative care with patients are trained in the formal academic training program in medical oncology in Flanders, Belgium. The programme is based on the recommendations for a Global Core Curriculum in Medical Oncology, developed by The American Society of Clinical Oncology (ASCO) together with the European Society for Medical Oncology (ESMO)...
January 4, 2017: Acta Clinica Belgica
https://www.readbyqxmd.com/read/28050924/inpatient-acupuncture-at-a-major-cancer-center
#11
M Kay Garcia, Lorenzo Cohen, Michael Spano, Amy Spelman, Yousra Hashmi, Alejandro Chaoul, Qi Wei, Gabriel Lopez
BACKGROUND: Use of complementary and integrative therapies is increasing among cancer patients, but data regarding the impact treatments such as acupuncture have in an inpatient oncology setting are limited. METHODS: Patients who received acupuncture in an inpatient hospital environment between December 2014 and December 2015 were asked to complete a modified Edmonton Symptom Assessment Scale (ESAS; 0-10 scale) before and after each visit. Pre- and post-treatment scores were examined for each symptom using paired t tests...
December 1, 2016: Integrative Cancer Therapies
https://www.readbyqxmd.com/read/28050132/early-integration-of-palliative-care-into-standard-oncology-care-evidence-and-overcoming-barriers-to-implementation
#12
D A Kain, E A Eisenhauer
No abstract text is available yet for this article.
December 2016: Current Oncology
https://www.readbyqxmd.com/read/28049576/provision-of-integrated-psychosocial-services-for-cancer-survivors-post-treatment
#13
REVIEW
Christopher J Recklitis, Karen L Syrjala
Meeting the psychosocial needs of patients with cancer has been recognised as a priority within oncology care for several decades. Many approaches that address these needs have been developed and described; however, until recently much of this work had focused on patients during treatment and end-of-life care. With continued improvement in therapies, the population of cancer survivors who can expect to live for 5 or more years after cancer diagnosis has increased dramatically, as have associated concerns about how to meet their medical, psychosocial, and health behaviour needs after treatment...
January 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28049575/integrating-primary-care-providers-in-the-care-of-cancer-survivors-gaps-in-evidence-and-future-opportunities
#14
REVIEW
Larissa Nekhlyudov, Denalee M O'malley, Shawna V Hudson
Since the release of the Institute of Medicine report: From cancer patient to cancer survivor: lost in transition, in 2005, there has been a national call in the USA to provide coordinated, comprehensive care for cancer survivors, with an emphasis on the role of primary care. Several models of care have been described, which focus on primary care providers (PCPs) as receiving cancer survivors who are transferred after successful treatment, and who are given specific types of information from oncology-based care (eg, survivorship care plans), and not as active members of the cancer survivorship team...
January 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28048916/mo-ab-204-02-ihe-rad
#15
J Seibert
: You've experienced the frustration: vendor A's device claims to work with vendor B's device, but the practice doesn't match the promise. Getting devices working together is the hidden art that Radiology and Radiation Oncology staff have to master. To assist with that difficult process, the Integrating the Healthcare Enterprise (IHE) effort was established in 1998, with the coordination of the Radiological Society of North America. Integrating the Healthcare Enterprise (IHE) is a consortium of healthcare professionals and industry partners focused on improving the way computer systems interconnect and exchange information...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048701/su-f-t-237-the-imaging-and-radiation-oncology-core-iroc-cooperatives-activities-supporting-the-nci-s-national-clinical-trial-network
#16
D Followill, J Galvin, J Michalski, M Rosen, T FitzGerald, M Knopp
PURPOSE: The Imaging and Radiation Oncology Core (IROC) Cooperative has been active for the past two years supporting the National Clinical Trial Network and the details of that support are reported. METHODS: There are six QA centers (Houston, Ohio, Philadelphia-RT, Philadelphia-DI, Rhode Island, St. Louis) providing an integrated RT and DI quality control program in support of the NCI's clinical trials. The QA Center's efforts are focused on assuring high quality data for clinical trials designed to improve the clinical outcomes for cancer patients worldwide...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048652/tu-d-brb-00-dual-energy-ct-in-radiation-therapy
#17
Zacariah Labby
: Dual-energy CT technology is becoming increasingly available to the medical imaging community. In addition, several models of CT simulators sold for use in radiation therapy departments now feature dual-energy technology. The images provided by dual-energy CT scanners add new information to the radiation treatment planning process; multiple spectral components can be used to separate and identify material composition as well as generate virtual monoenergetic images. In turn, this information could be used to investigate pathologic processes, separate the properties of contrast agents from soft tissues, assess tissue response to therapy, and other applications of therapeutic interest...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048449/we-d-204-04-learning-the-ropes-clinical-immersion-in-the-first-month-of-residency
#18
S Dieterich
: Speakers in this session will present overview and details of a specific rotation or feature of their Medical Physics Residency Program that is particularly exceptional and noteworthy. The featured rotations include foundational topics executed with exceptional acumen and innovative educational rotations perhaps not commonly found in Medical Physics Residency Programs. A site-specific clinical rotation will be described, where the medical physics resident follows the physician and medical resident for two weeks into patient consultations, simulation sessions, target contouring sessions, planning meetings with dosimetry, patient follow up visits, and tumor boards, to gain insight into the thought processes of the radiation oncologist...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048408/su-f-t-495-method-for-simultaneous-commissioning-of-multiple-truebeam-tb-linacs-small-field-data-and-the-choice-of-dosimetric-lead-gap-dlg
#19
D Mihailidis, J Mallah
PURPOSE: Many times a set of multiple Varian-Truebeam (TB) linacs are acquired by an institution. Since "beam matching" is an important requirement for many facilities, we developed a strategy to perform a "simultaneous" commissioning between multiple linacs. METHODS AND MATERIALS: We first commissioned the required photon beam data for eclipse on the 1st TB for all the energy modalities with a beam scanning system, while integrated measurements for output factors, of all field sizes (from 1×1 to 40×40cm(2) ) were conducted on the 2nd TB...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28048382/su-g-jep2-15-proton-beam-behavior-in-the-presence-of-realistic-magnet-fields
#20
D M Santos, K Wachowicz, B G Fallone
PURPOSE: To investigate the effects of magnetic fields on proton therapy beams for integration with MRI. METHODS: 3D magnetic fields from an open-bore superconducting MRI model (previously developed by our group) and 3D magnetic fields from an in-house gradient coil design were applied to various mono energetic proton pencil beam (80MeV to 250MeV) simulations. In all simulations, the z-axis of the simulation geometry coincided with the direction of the B0 field and magnet isocentre...
June 2016: Medical Physics
keyword
keyword
13164
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"